Mirabegron Ameliorated Atherosclerosis of ApoE −/− Mice in Chronic Intermittent Hypoxia but Not in Normoxia
ConclusionThis study first demonstrated that mirabegron impeded the progression of CIH-induced atherosclerosis, at least in part, via β3 AR–mediated oxidative stress, suggesting a promising therapeutic strategy for protecting against atherosclerosis induced by CIH.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Heart | High Fat | Nutrition | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study